Literature DB >> 21326755

Complications of hepatic chemoembolization.

Timothy W I Clark1.   

Abstract

Transarterial hepatic chemoembolization continues to evolve as an integral therapy for unresectable primary and secondary liver tumors. Despite relatively low morbidity, major complications may be seen. This article provides an overview of the spectrum of vascular and nonvascular complications related to this therapy.

Entities:  

Keywords:  Hepatic chemoembolization; complications; hepatocellular carcinoma; liver metastases

Year:  2006        PMID: 21326755      PMCID: PMC3036366          DOI: 10.1055/s-2006-941442

Source DB:  PubMed          Journal:  Semin Intervent Radiol        ISSN: 0739-9529            Impact factor:   1.513


  38 in total

1.  Ischemic complications of transcatheter arterial chemoembolization in liver malignancies.

Authors:  P G Tarazov; V N Polysalov; K V Prozorovskij; I V Grishchenkova; E V Rozengauz
Journal:  Acta Radiol       Date:  2000-03       Impact factor: 1.990

2.  Effectiveness of an aggressive antibiotic regimen for chemoembolization in patients with previous biliary intervention.

Authors:  Shalin Patel; Catherine M Tuite; Jeffrey I Mondschein; Michael C Soulen
Journal:  J Vasc Interv Radiol       Date:  2006-12       Impact factor: 3.464

3.  Subphrenic abscess formation following superselective transcatheter chemoembolization for hepatocellular carcinoma.

Authors:  Yoshihiro Yokoi; Shohachi Suzuki; Takanori Sakaguchi; Takuya Okumura; Kiyotaka Kurachi; Hiroyuki Konno; Satoshi Nakamura
Journal:  Radiat Med       Date:  2002 Jan-Feb

4.  Factors influencing mortality in the treatment of pyogenic hepatic abscess.

Authors:  H A Pitt; G D Zuidema
Journal:  Surg Gynecol Obstet       Date:  1975-02

5.  Rare pulmonary complications after transarterial chemoembolisation for hepatocellular carcinoma: two case reports.

Authors:  P C H Kwok; T W Lam; C L Lam; A K H Lai; H Y Lo; S C H Chan
Journal:  Hong Kong Med J       Date:  2003-12       Impact factor: 2.227

6.  Infectious complications of hepatic artery catheterization procedures in patients with cancer.

Authors:  E Wong; N Khardori; C H Carrasco; S Wallace; Y Patt; G P Bodey
Journal:  Rev Infect Dis       Date:  1991 Jul-Aug

7.  Postmortem survey of bile duct necrosis and biloma in hepatocellular carcinoma after transcatheter arterial chemoembolization therapy: relevance to microvascular damages of peribiliary capillary plexus.

Authors:  S Kobayashi; Y Nakanuma; T Terada; O Matsui
Journal:  Am J Gastroenterol       Date:  1993-09       Impact factor: 10.864

8.  Pulmonary oil embolism after transcatheter oily chemoembolization of hepatocellular carcinoma.

Authors:  J W Chung; J H Park; J G Im; J K Han; M C Han
Journal:  Radiology       Date:  1993-06       Impact factor: 11.105

9.  Hepatic tumors: predisposing factors for complications of transcatheter oily chemoembolization.

Authors:  J W Chung; J H Park; J K Han; B I Choi; M C Han; H S Lee; C Y Kim
Journal:  Radiology       Date:  1996-01       Impact factor: 11.105

10.  Iatrogenic dissection of the celiac artery and its branches during transcatheter arterial embolization for hepatocellular carcinoma: outcome in 40 patients.

Authors:  D Y Yoon; J H Park; J W Chung; J K Han; M C Han
Journal:  Cardiovasc Intervent Radiol       Date:  1995 Jan-Feb       Impact factor: 2.740

View more
  32 in total

1.  Hepatic Arterial Infusion of Low-Density Lipoprotein Docosahexaenoic Acid Nanoparticles Selectively Disrupts Redox Balance in Hepatoma Cells and Reduces Growth of Orthotopic Liver Tumors in Rats.

Authors:  Xiaodong Wen; Lacy Reynolds; Rohit S Mulik; Soo Young Kim; Tim Van Treuren; Liem H Nguyen; Hao Zhu; Ian R Corbin
Journal:  Gastroenterology       Date:  2015-10-17       Impact factor: 22.682

2.  Anatomical variations of the celiac trunk: cadaveric and radiological study.

Authors:  I Marco-Clement; A Martinez-Barco; N Ahumada; C Simon; J M Valderrama; J Sanudo; J Arrazola
Journal:  Surg Radiol Anat       Date:  2015-08-13       Impact factor: 1.246

Review 3.  Imaging appearance of treated hepatocellular carcinoma.

Authors:  Francesco Agnello; Giuseppe Salvaggio; Giuseppe Cabibbo; Marcello Maida; Roberto Lagalla; Massimo Midiri; Giuseppe Brancatelli
Journal:  World J Hepatol       Date:  2013-08-27

Review 4.  Locoregional and systemic therapy for hepatocellular carcinoma.

Authors:  Olumide B Gbolahan; Michael A Schacht; Eric W Beckley; Thomas P LaRoche; Bert H O'Neil; Maximilian Pyko
Journal:  J Gastrointest Oncol       Date:  2017-04

5.  Post-embolization syndrome as an early predictor of overall survival after transarterial chemoembolization for hepatocellular carcinoma.

Authors:  Meredith C Mason; Nader N Massarweh; Aitua Salami; Mark A Sultenfuss; Daniel A Anaya
Journal:  HPB (Oxford)       Date:  2015-09-16       Impact factor: 3.647

6.  Hepatic artery and biliary complications in liver transplant recipients undergoing pretransplant transarterial chemoembolization.

Authors:  Aparna Goel; Neil Mehta; Jennifer Guy; Nicholas Fidelman; Francis Yao; John Roberts; Norah Terrault
Journal:  Liver Transpl       Date:  2014-10       Impact factor: 5.799

Review 7.  Tumor thrombus: incidence, imaging, prognosis and treatment.

Authors:  Keith Bertram Quencer; Tamir Friedman; Rahul Sheth; Rahmi Oklu
Journal:  Cardiovasc Diagn Ther       Date:  2017-12

Review 8.  Hepatocellular carcinoma rupture following transarterial chemoembolization.

Authors:  Nimarta Singh Bhinder; Steven M Zangan
Journal:  Semin Intervent Radiol       Date:  2015-03       Impact factor: 1.513

9.  In situ gelling silk-elastinlike protein polymer for transarterial chemoembolization.

Authors:  Azadeh Poursaid; Robert Price; Andrea Tiede; Erik Olson; Eugene Huo; Lawrence McGill; Hamidreza Ghandehari; Joseph Cappello
Journal:  Biomaterials       Date:  2015-04-28       Impact factor: 12.479

Review 10.  Current and future treatments for hepatocellular carcinoma.

Authors:  Alexander Schlachterman; Willie W Craft; Eric Hilgenfeldt; Avir Mitra; Roniel Cabrera
Journal:  World J Gastroenterol       Date:  2015-07-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.